Wilmar International - Maybank Research 2026-03-10: Operational Resilience; Regulatory Risks Fading – Upgrade To BUY

• We believe the bulk of regulatory overhangs are now largely behind Wilmar (SGX:F34), with adequate provisions already recognised. With earnings on an upward trajectory and leverage trending lower, balance sheet flexibility is improving, creating scope for potential dividend enhancement. A weaker US$ also provides an incremental earnings tailwind.

Resilient FY25 performance.

• - Read this at SGinvestors.io -

Granular outlook points to stable growth trajectory.

• - Read this at SGinvestors.io -
• Global supply-demand dynamics support stable pricing and positive refining margins in Indonesia and Malaysia. Although soybean crushing margins are expected to soften and plantation output was weak in early 2026, recovery is anticipated.
• Net capex is set to remain stable despite AWL integration, reinforcing cash flow discipline.

Regulatory risks behind; Iran conflict impact mixed.

• Read more at SGinvestors.io.

Above is an excerpt from a report by Maybank Research.
Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.

Previous report by Maybank:
2025-09-29 Wilmar International - Taking Pause Amid Regulatory Scrutiny; Downgrade To HOLD.

Price targets by 3 other brokers at Wilmar Target Prices.

Listing of research reports at Wilmar Analyst Reports.

Relevant links:
Wilmar Share Price History,
Wilmar Announcements,
Wilmar Dividend Payout Dates & Corporate Actions,
Wilmar News